Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Res. 2018 Dec 11;79(3):482–494. doi: 10.1158/0008-5472.CAN-18-1214

Figure 6.

Figure 6.

Hypothetical model. Tet2 depletion together with Nras mutation increase melanoma incidence and reduces the latency. In cooperation with Nras activation, Tet2 depletion would favor cell immortalization and facilitate melanoma emergence by (i) reducing cell-cycle inhibitor/tumor suppressor expression; (ii) allowing Akt activation, and (iii) reducing the hydroxymethylome plasticity, a bunch of phenomena that influence tumor homeostasis.